세포 생존율 어세이 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Cell Viability Assays Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Application (Basic Research, Stem Cell Research), By End Users, By Region - Industry Forecast 2024-2031
상품코드:1593533
리서치사:SkyQuest
발행일:2024년 11월
페이지 정보:영문 194 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 세포 생존율 어세이 시장 규모는 2022년 13억 8,000만 달러로 평가되며, 2023년 15억 2,000만 달러에서 2031년 32억 4,000만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 9.94%의 CAGR로 성장할 것으로 예상됩니다.
세계 세포 생존율 어세이(CVA) 시장은 의약품 개발 수요 증가와 제약 및 생명공학 분야의 발전에 힘입어 크게 성장하고 있습니다. 세포 생존율은 독성 인자를 포함한 화학적 또는 물리적 요인에 의해 영향을 받는 세포 건강의 중요한 지표로, CVA는 약물이나 병원체에 대한 세포의 반응을 평가하는 데 필수적인 도구로 초기 단계의 신약 개발에 필수적인 도구가 되고 있습니다. 이러한 분석은 화합물의 효율성, 독성 및 안전성 프로파일을 평가하는 데 도움이 되며, 이는 의약품 개발에 필수적입니다. 제약 업계가 새로운 치료법과 약물 안전성에 중점을 두면서 세포 생존율 어세이에 대한 수요가 확대되고 의학 연구 및 약물 검사에 대한 응용이 더욱 확대될 것으로 예상됩니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차·1차 정보 출처
시장 규모 추정
시장 가정과 제한
주요 요약
세계 시장 전망
공급 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석과 영향
경쟁 기업 간의 경쟁 관계
대체품의 위협
구매자의 교섭력
신규 참여업체의 위협
공급 기업의 교섭력
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
기술의 진보
규제 상황
특허 분석
밸류체인 분석
사례 연구 분석
고객과 구매 기준 분석
PESTEL 분석
거시경제 지표
시장 매력 지수
세포 생존율 어세이 시장 규모 : 제품별, CAGR(2024-2031년)
시장 개요
소모품
기기
세포 생존율 어세이 시장 규모 : 용도별, CAGR(2024-2031년)
시장 개요
기초 연구
줄기세포 연구
Drug Discovery & Development
임상·진단 용도
기타 용도
세포 생존율 어세이 시장 규모 : 최종사용자별, CAGR(2024-2031년)
시장 개요
학술연구기관
제약·바이오테크놀러지 기업
병원·진단 검사실
기타 최종사용자
세포 생존율 어세이 시장 규모&와 CAGR(2024-2031년)
북미(제품, 용도, 최종사용자)
미국
캐나다
유럽(제품, 용도, 최종사용자)
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양(제품, 용도, 최종사용자)
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카(제품, 용도, 최종사용자)
브라질
기타 라틴아메리카
중동 및 아프리카(제품, 용도, 최종사용자)
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2021-2023년)
주요 기업 개요
F. Hoffmann-La Roche AG
Danaher Corporation
Lonza Group AG
Promega Corporation
Charles River Laboratories International, Inc.
Menarini Silicon Biosystems, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Macrogen Inc
DiscoverX Corporation
Corning Inc.
Merck KGaA
Thermo Fisher Scientific Inc.
Perkinelmer, Inc.
Biognosys
Cell Signaling Technology, Inc.
Lebermuth, Inc.
Eurofins DiscoverX Products
GE Healthcare
Beckman Coulter,Inc.
결론과 추천사항
ksm
영문 목차
영문목차
Global Cell Viability Assays Market size was valued at USD 1.38 Billion in 2022 and is poised to grow from USD 1.52 Billion in 2023 to USD 3.24 Billion by 2031, growing at a CAGR of 9.94% in the forecast period (2024-2031).
The global Cell Viability Assays (CVA) market is witnessing significant growth, driven by the increasing demand for drug development and advancements in the pharmaceutical and biotechnology sectors. Cell viability, a critical indicator of cell health, is affected by chemical or physical agents, including toxicity factors. CVAs are essential tools for assessing cellular responses to drugs or pathogens, making them indispensable in early-stage drug discovery. These assays help evaluate compound efficiency, toxicity, and safety profiles, which are vital for drug development. As the pharmaceutical industry focuses on novel therapies and drug safety, the demand for cell viability assays is expected to grow, further expanding their applications in medical research and drug testing.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Viability Assays Market Segmental Analysis
Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Cell Viability Assays Market
The continuous investment in research and development by manufacturers to introduce new drugs for treating various conditions is a significant driver in the global Cell Viability Assays market. The pharmaceutical and biotechnology industries heavily rely on cell viability assays for critical processes such as drug discovery, toxicity testing, and evaluating drug efficiency. This ongoing development and innovation within these sectors are driving the growing demand for advanced assays, as they play a crucial role in ensuring the safety and efficacy of new therapeutics. As these industries expand, the need for more precise and reliable assays continues to rise, further fueling market growth.
Restraints in the Global Cell Viability Assays Market
The global Cell Viability Assays market faces significant restraints due to strict regulations on the use of reagents, which impede market growth. Additionally, the high cost of necessary instruments further limits expansion. Certain cell-based assays require specific reagents, such as antibodies, growth factors, cytokines, or fluorescent dyes, to detect and measure cellular responses. These specialized reagents often face limitations due to intellectual property rights, licensing agreements, or limited commercial availability, further hindering market development. As a result, the combination of regulatory restrictions and high costs of both reagents and instruments presents a substantial challenge to the growth of the cell viability assay market.
Market Trends of the Global Cell Viability Assays Market
Continuous innovation in the characteristics of cell viability assays is driving the growth of the global market. Manufacturers are increasingly integrating these assays with emerging technologies such as artificial intelligence (AI) and machine learning, significantly enhancing data analysis, interpretation, and overall assay performance. These advancements not only improve the accuracy and efficiency of cell viability testing but also contribute to more reliable and faster results, which is fostering the growth of the market. As these technologies evolve, the demand for advanced, high-performance cell viability assays continues to rise, further accelerating market expansion.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Customer & Buying Criteria Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index
Global Cell Viability Assays Market Size byProduct & CAGR (2024-2031)
Market Overview
Consumables
Instruments
Global Cell Viability Assays Market Size byApplication & CAGR (2024-2031)
Market Overview
Basic Research
Stem Cell Research
Drug Discovery & Development
Clinical & Diagnostic Applications
Other Applications
Global Cell Viability Assays Market Size by End User & CAGR (2024-2031)
Market Overview
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Hospital and Diagnostic Laboratories
Other End Users
Global Cell Viability Assays Market Size & CAGR (2024-2031)
North America, (Product, Application, End User)
US
Canada
Europe, (Product, Application, End User)
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific, (Product, Application, End User)
China
India
Japan
South Korea
Rest of Asia Pacific
Latin America, (Product, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa, (Product, Application, End User)
